Experimental cell therapy targets Hard-to-Treat cancers
Disease control
Not yet recruiting
This early-phase study tests a new cell therapy called KT032 in 24 adults with advanced solid tumors (ovarian, mesothelioma, colon cancer) that have spread to the abdomen and haven't responded to standard treatments. The main goal is to check safety and find the best dose, while …
Phase: EARLY_PHASE1 • Sponsor: Weijia Fang, MD • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC